CUFinder

Fiona Brown

Fiona Brown

Monash University

H-index: 14

Oceania-Australia

Contact Fiona Brown

About Fiona Brown

Fiona Brown, With an exceptional h-index of 14 and a recent h-index of 13 (since 2020), a distinguished researcher at Monash University, specializes in the field of Acute myeloid leukemia, hematopoiesis, genomics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Is BCL-xL the Achilles' heel of AEL and AMKL?

Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia

Cellular distribution of IDH mutations in AML during morphologic remission

Pharmacologic reduction of mitochondrial iron triggers a noncanonical BAX/BAK-dependent cell death

Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance

The AP-1/ETS Transcription Factor Network Regulates Stem Cell Quiescence and Chemotherapy Resistance in Acute Myeloid Leukemia

Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses

Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia

Fiona Brown Information

University

Position

Research Fellow

Citations(all)

1352

Citations(since 2020)

1256

Cited By

386

hIndex(all)

14

hIndex(since 2020)

13

i10Index(all)

18

i10Index(since 2020)

15

Email

University Profile Page

Google Scholar

Fiona Brown Skills & Research Interests

Acute myeloid leukemia

hematopoiesis

genomics

Top articles of Fiona Brown

Is BCL-xL the Achilles' heel of AEL and AMKL?

Blood, The Journal of the American Society of Hematology

2023/3/30

Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia

Blood

2023/2/9

Sarah Macraild
Sarah Macraild

H-Index: 10

Rhiannon Morris
Rhiannon Morris

H-Index: 0

Cellular distribution of IDH mutations in AML during morphologic remission

Leukemia Research

2023/1/1

Radha Ramanan
Radha Ramanan

H-Index: 8

Pharmacologic reduction of mitochondrial iron triggers a noncanonical BAX/BAK-dependent cell death

Cancer Discovery

2022/3/1

Sebastian Müller
Sebastian Müller

H-Index: 3

Caitlin L Rowe
Caitlin L Rowe

H-Index: 5

Kevin Tran
Kevin Tran

H-Index: 8

Georg Ramm
Georg Ramm

H-Index: 29

Kate Mcarthur
Kate Mcarthur

H-Index: 13

Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance

bioRxiv

2022

The AP-1/ETS Transcription Factor Network Regulates Stem Cell Quiescence and Chemotherapy Resistance in Acute Myeloid Leukemia

Blood

2022/11/15

Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses

Cancer cell

2022/10/10

Juliana Gomez
Juliana Gomez

H-Index: 5

Chelisa Cardinez
Chelisa Cardinez

H-Index: 1

Nishi Kumari
Nishi Kumari

H-Index: 9

Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia

EMBO Molecular Medicine

2022/7/7

Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias

Blood, The Journal of the American Society of Hematology

2021/5/20

Donia Moujalled
Donia Moujalled

H-Index: 12

Sarah Macraild
Sarah Macraild

H-Index: 10

Maoshan Chen
Maoshan Chen

H-Index: 21

Catherine Chang
Catherine Chang

H-Index: 26

Zhen Xu
Zhen Xu

H-Index: 3

Chemotherapy and venetoclax in elderly acute myeloid leukemia trial (CAVEAT): a phase Ib dose-escalation study of venetoclax combined with modified intensive chemotherapy

Journal of Clinical Oncology

2020/10/20

John Reynolds
John Reynolds

H-Index: 2

Sarah Macraild
Sarah Macraild

H-Index: 10

Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML

Blood, The Journal of the American Society of Hematology

2020/3/12

Xufeng Chen
Xufeng Chen

H-Index: 7

See List of Professors in Fiona Brown University(Monash University)